These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1718 related items for PubMed ID: 8425193

  • 1. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 2. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
    Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW.
    J Immunol; 1994 Sep 01; 153(5):2213-21. PubMed ID: 8051421
    [Abstract] [Full Text] [Related]

  • 3. C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.
    Ollert MW, Frade R, Fiandino A, Panneerselvam M, Petrella EC, Barel M, Pangburn MK, Bredehorst R, Vogel CW.
    J Immunol; 1990 May 15; 144(10):3862-7. PubMed ID: 2185316
    [Abstract] [Full Text] [Related]

  • 4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 7. A molecular mechanism of complement resistance of human melanoma cells.
    Panneerselvam M, Welt S, Old LJ, Vogel CW.
    J Immunol; 1986 Apr 01; 136(7):2534-41. PubMed ID: 3081645
    [Abstract] [Full Text] [Related]

  • 8. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 01; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 9. Phylogeny of C4b-C3b cleaving activity: similar fragmentation patterns of human C4b and C3b produced by lower animals.
    Kaidoh T, Gigli I.
    J Immunol; 1987 Jul 01; 139(1):194-201. PubMed ID: 3295051
    [Abstract] [Full Text] [Related]

  • 10. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 11. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH, Hänsch G, Gresham HD, Shin ML.
    J Immunol; 1983 Aug 01; 131(2):892-8. PubMed ID: 6863934
    [Abstract] [Full Text] [Related]

  • 12. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N, Pangburn MK.
    Mol Immunol; 2007 Feb 01; 44(6):1105-14. PubMed ID: 16979240
    [Abstract] [Full Text] [Related]

  • 13. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar 01; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 15. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.
    Biochemistry; 2009 Sep 08; 48(35):8466-72. PubMed ID: 19642650
    [Abstract] [Full Text] [Related]

  • 16. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO, Jaikaran AS, Carroll MC, Anderson MJ, Campbell RD, Isenman DE.
    J Immunol; 1992 May 01; 148(9):2803-11. PubMed ID: 1573269
    [Abstract] [Full Text] [Related]

  • 17. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM, Da Silva RP, Sacks DL, Hammer CH, Joiner KA.
    J Immunol; 1990 Dec 15; 145(12):4311-6. PubMed ID: 2147941
    [Abstract] [Full Text] [Related]

  • 18. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
    Norris KA.
    Microb Pathog; 1996 Oct 15; 21(4):235-48. PubMed ID: 8905613
    [Abstract] [Full Text] [Related]

  • 19. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 20. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG, Melamed J, Arnaout MA.
    Eur J Immunol; 1983 Jun 01; 13(6):465-70. PubMed ID: 6222909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.